Annual Operating Profit
$13.54 B
-$5.28 B-28.06%
31 December 2023
Summary:
AbbVie annual operaing income is currently $13.54 billion, with the most recent change of -$5.28 billion (-28.06%) on 31 December 2023. During the last 3 years, it has risen by +$796.00 million (+6.25%). ABBV annual operating profit is now -28.94% below its all-time high of $19.05 billion, reached on 31 December 2021.ABBV Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$3.91 B
-$1.02 B-20.71%
30 September 2024
Summary:
AbbVie quarterly operating income is currently $3.91 billion, with the most recent change of -$1.02 billion (-20.71%) on 30 September 2024. Over the past year, it has increased by +$1.63 billion (+71.55%). ABBV quarterly operating profit is now -28.88% below its all-time high of $5.50 billion, reached on 31 December 2022.ABBV Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$15.01 B
+$1.63 B+12.20%
30 September 2024
Summary:
AbbVie TTM operating income is currently $15.01 billion, with the most recent change of +$1.63 billion (+12.20%) on 30 September 2024. Over the past year, it has dropped by -$489.00 million (-3.16%). ABBV TTM operating profit is now -19.06% below its all-time high of $18.54 billion, reached on 31 March 2022.ABBV TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.1% | +71.5% | -3.2% |
| 3 y3 years | +6.3% | -9.1% | -9.6% |
| 5 y5 years | +98.8% | +49.5% | +127.8% |
ABBV Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.9% | +6.3% | -28.9% | +71.5% | -19.1% | +13.8% |
| 5 y | 5 years | -28.9% | +98.8% | -28.9% | +420.4% | -19.1% | +127.8% |
| alltime | all time | -28.9% | +259.7% | -28.9% | +260.3% | -19.1% | +1523.2% |
AbbVie Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.91 B(-20.7%) | $15.01 B(+12.2%) |
| June 2024 | - | $4.93 B(+66.6%) | $13.37 B(+1.1%) |
| Mar 2024 | - | $2.96 B(-7.3%) | $13.23 B(+0.3%) |
| Dec 2023 | $13.54 B(-28.1%) | $3.19 B(+40.1%) | $13.19 B(-14.9%) |
| Sept 2023 | - | $2.28 B(-52.4%) | $15.49 B(-13.0%) |
| June 2023 | - | $4.79 B(+64.3%) | $17.82 B(+9.2%) |
| Mar 2023 | - | $2.92 B(-47.0%) | $16.32 B(-9.9%) |
| Dec 2022 | $18.81 B(-1.2%) | $5.50 B(+19.5%) | $18.12 B(+2.4%) |
| Sept 2022 | - | $4.60 B(+39.7%) | $17.69 B(+1.7%) |
| June 2022 | - | $3.29 B(-30.1%) | $17.39 B(-6.2%) |
| Mar 2022 | - | $4.72 B(-7.0%) | $18.54 B(+3.4%) |
| Dec 2021 | $19.05 B(+49.5%) | $5.07 B(+17.8%) | $17.92 B(+8.0%) |
| Sept 2021 | - | $4.31 B(-3.0%) | $16.60 B(+6.8%) |
| June 2021 | - | $4.44 B(+8.2%) | $15.55 B(+31.1%) |
| Mar 2021 | - | $4.10 B(+9.3%) | $11.86 B(+4.4%) |
| Dec 2020 | $12.74 B(-4.7%) | $3.75 B(+15.3%) | $11.36 B(-1.8%) |
| Sept 2020 | - | $3.25 B(+332.8%) | $11.57 B(+5.8%) |
| June 2020 | - | $752.00 M(-79.1%) | $10.93 B(-19.5%) |
| Mar 2020 | - | $3.60 B(-8.9%) | $13.58 B(+4.6%) |
| Dec 2019 | $13.37 B(+96.4%) | $3.96 B(+51.2%) | $12.98 B(+97.1%) |
| Sept 2019 | - | $2.62 B(-23.0%) | $6.59 B(-7.6%) |
| June 2019 | - | $3.40 B(+13.0%) | $7.13 B(+9.8%) |
| Mar 2019 | - | $3.01 B(-223.3%) | $6.49 B(+1.7%) |
| Dec 2018 | $6.81 B(-31.0%) | -$2.44 B(-177.3%) | $6.38 B(-39.8%) |
| Sept 2018 | - | $3.16 B(+14.4%) | $10.61 B(+4.6%) |
| June 2018 | - | $2.76 B(-4.9%) | $10.14 B(+1.0%) |
| Mar 2018 | - | $2.90 B(+62.9%) | $10.04 B(+5.2%) |
| Dec 2017 | $9.87 B | $1.78 B(-33.9%) | $9.54 B(-5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $2.69 B(+1.2%) | $10.08 B(+3.4%) |
| June 2017 | - | $2.66 B(+10.6%) | $9.74 B(+2.9%) |
| Mar 2017 | - | $2.41 B(+4.0%) | $9.47 B(+1.4%) |
| Dec 2016 | $9.54 B(+24.1%) | $2.31 B(-2.0%) | $9.34 B(+2.2%) |
| Sept 2016 | - | $2.36 B(-1.1%) | $9.14 B(+5.5%) |
| June 2016 | - | $2.39 B(+4.8%) | $8.66 B(+6.6%) |
| Mar 2016 | - | $2.28 B(+7.8%) | $8.13 B(+7.8%) |
| Dec 2015 | $7.69 B(+104.3%) | $2.11 B(+12.1%) | $7.54 B(+50.5%) |
| Sept 2015 | - | $1.89 B(+1.8%) | $5.01 B(+22.6%) |
| June 2015 | - | $1.85 B(+9.8%) | $4.08 B(+9.0%) |
| Mar 2015 | - | $1.69 B(-506.5%) | $3.75 B(+9.9%) |
| Dec 2014 | $3.76 B(-37.3%) | -$415.00 M(-143.2%) | $3.41 B(-36.4%) |
| Sept 2014 | - | $960.00 M(-36.6%) | $5.36 B(-7.1%) |
| June 2014 | - | $1.51 B(+12.1%) | $5.77 B(+1.1%) |
| Mar 2014 | - | $1.35 B(-12.0%) | $5.71 B(+0.8%) |
| Dec 2013 | $6.00 B(-1.7%) | $1.53 B(+12.0%) | $5.66 B(-4.8%) |
| Sept 2013 | - | $1.37 B(-5.6%) | $5.95 B(-3.6%) |
| June 2013 | - | $1.45 B(+11.3%) | $6.17 B(+0.5%) |
| Mar 2013 | - | $1.30 B(-28.3%) | $6.14 B(+5.6%) |
| Dec 2012 | $6.11 B(+42.2%) | $1.82 B(+14.1%) | $5.82 B(+14.0%) |
| Sept 2012 | - | $1.60 B(+12.2%) | $5.10 B(+43.3%) |
| June 2012 | - | $1.42 B(+45.4%) | $3.56 B(-3.1%) |
| Mar 2012 | - | $978.00 M(-11.5%) | $3.67 B(+1.5%) |
| Dec 2011 | $4.29 B(-14.7%) | $1.11 B(+1962.2%) | $3.62 B(+44.0%) |
| Sept 2011 | - | $53.61 M(-96.5%) | $2.51 B(+2.2%) |
| June 2011 | - | $1.54 B(+66.2%) | $2.46 B(+166.2%) |
| Mar 2011 | - | $924.44 M | $924.44 M |
| Dec 2010 | $5.03 B(-1.4%) | - | - |
| Dec 2009 | $5.10 B | - | - |
FAQ
- What is AbbVie annual operaing income?
- What is the all time high annual operating profit for AbbVie?
- What is AbbVie annual operating profit year-on-year change?
- What is AbbVie quarterly operating income?
- What is the all time high quarterly operating profit for AbbVie?
- What is AbbVie quarterly operating profit year-on-year change?
- What is AbbVie TTM operating income?
- What is the all time high TTM operating profit for AbbVie?
- What is AbbVie TTM operating profit year-on-year change?
What is AbbVie annual operaing income?
The current annual operating profit of ABBV is $13.54 B
What is the all time high annual operating profit for AbbVie?
AbbVie all-time high annual operaing income is $19.05 B
What is AbbVie annual operating profit year-on-year change?
Over the past year, ABBV annual operaing income has changed by -$5.28 B (-28.06%)
What is AbbVie quarterly operating income?
The current quarterly operating profit of ABBV is $3.91 B
What is the all time high quarterly operating profit for AbbVie?
AbbVie all-time high quarterly operating income is $5.50 B
What is AbbVie quarterly operating profit year-on-year change?
Over the past year, ABBV quarterly operating income has changed by +$1.63 B (+71.55%)
What is AbbVie TTM operating income?
The current TTM operating profit of ABBV is $15.01 B
What is the all time high TTM operating profit for AbbVie?
AbbVie all-time high TTM operating income is $18.54 B
What is AbbVie TTM operating profit year-on-year change?
Over the past year, ABBV TTM operating income has changed by -$489.00 M (-3.16%)